Yet thanks to a new hospital-based educational and advocacy initiative for COPD patients, Croswell has been managing well at ...

A new study published in the Journal of the COPD Foundation showed that perceived stress significantly worsens respiratory ...

In a recent paper, researchers recommended prompt screening methods and management strategies for comorbidities that occur commonly in patients with COPD.

Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...

The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult ...

Canadian wildfire smoke has entered the Upper Midwest and poses significant health impacts in the hardest-hit areas.

The U.S. Food and Drug Administration has approved Nucala as a supplementary treatment for elderly individuals with severe chronic obstructive pulmonary disease .Nucala is the only approved biologic, ...

The US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive ...

Exacerbations are acute episodes of worsening COPD symptoms that can lead to hospitalization and irreversible lung damage. Preventing exacerbations is a key goal for managing COPD. COPD is a life ...

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the classic male presentation.

Panelists discuss how differentiating primary from secondary erythrocytosis is crucial in guiding treatment strategies, emphasizing the importance of addressing underlying causes such as chronic ...

FDA approves Nucala as add-on therapy for COPD with high eosinophils, offering new hope by reducing flare-ups in patients unresponsive to inhaled treatments.